![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » POZEN, INC. ANNOUNCES RECEIPT OF $40 MILLION UPFRONT PAYMENT FROM ASTRAZENECA PL
POZEN, INC. ANNOUNCES RECEIPT OF $40 MILLION UPFRONT PAYMENT FROM ASTRAZENECA PL
POZEN Inc., announced the receipt of the $40 million initial upfront payment from AstraZeneca in connection with the exclusive global collaboration agreement between the two companies. The previously announced collaboration with AstraZeneca has cleared the waiting period required under the Hart-Scott-Rodino Anti-trust Improvements Act making the agreement effective.
BioSpace (http://www.biospace.com/news_story.aspx?StoryID=30678&full=1)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
11Jul
-
18Jul
-
21Oct